# REMASTer: REcurrent Brain Metastases After SRS Trial

> **NCT05124912** · NA · RECRUITING · sponsor: **Monteris Medical** · enrollment: 261 (estimated)

## Conditions studied

- Brain Metastases
- Radiation Necrosis
- Recurrent Tumor
- Recurrent Metastases

## Interventions

- **PROCEDURE:** Radiation Therapy
- **DRUG:** Steroid Therapy
- **PROCEDURE:** Laser Interstitial Thermal Therapy

## Key facts

- **NCT ID:** NCT05124912
- **Lead sponsor:** Monteris Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-10
- **Primary completion:** 2026-12
- **Final completion:** 2028-10
- **Target enrollment:** 261 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05124912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05124912, "REMASTer: REcurrent Brain Metastases After SRS Trial". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05124912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*